Literature DB >> 16565482

Commonality of defensive roles of COX-2 in the lung and gut.

John L Wallace1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16565482      PMCID： PMC1606548          DOI： 10.2353/ajpath.2006.060023

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  32 in total

1.  Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

Authors:  Peter Jüni; Anne W S Rutjes; Paul A Dieppe
Journal:  BMJ       Date:  2002-06-01

2.  Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage.

Authors:  Stefano Fiorucci; Octavio Menezes de Lima; Andrea Mencarelli; Barbara Palazzetti; Eleonora Distrutti; Webb McKnight; Michael Dicay; Li Ma; Mario Romano; Antonio Morelli; John L Wallace
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  The apical surface of canine chief cell monolayers resists H+ back-diffusion.

Authors:  M J Sanders; A Ayalon; M Roll; A H Soll
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

4.  Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.

Authors:  B Gretzer; N Maricic; M Respondek; R Schuligoi; B M Peskar
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.

Authors:  Akiko Tanaka; Shoko Hase; Tohru Miyazawa; Koji Takeuchi
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

6.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

Authors:  W L Xie; J G Chipman; D L Robertson; R L Erikson; D L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Authors:  J L Masferrer; B S Zweifel; P T Manning; S D Hauser; K M Leahy; W G Smith; P C Isakson; K Seibert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 8.  Lipoxins: endogenous regulators of inflammation.

Authors:  Blaithin McMahon; Catherine Godson
Journal:  Am J Physiol Renal Physiol       Date:  2004-02

9.  Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.

Authors:  J Clària; C N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

10.  Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway.

Authors:  Christopher L Karp; Leah M Flick; Kiwon W Park; Samir Softic; Todd M Greer; Raquel Keledjian; Rong Yang; Jasim Uddin; William B Guggino; Sowsan F Atabani; Yasmine Belkaid; Yan Xu; Jeffrey A Whitsett; Frank J Accurso; Marsha Wills-Karp; Nicos A Petasis
Journal:  Nat Immunol       Date:  2004-03-21       Impact factor: 25.606
View more
  3 in total

1.  Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection.

Authors:  Zaher A Radi; David K Meyerholz; Mark R Ackermann
Journal:  Viral Immunol       Date:  2010-02       Impact factor: 2.257

Review 2.  Current concepts regarding the pathogenesis of necrotizing enterocolitis.

Authors:  Mikael Petrosyan; Yigit S Guner; Monica Williams; Anatoly Grishin; Henri R Ford
Journal:  Pediatr Surg Int       Date:  2009-03-20       Impact factor: 1.827

3.  Comparison of two human organoid models of lung and intestinal inflammation reveals Toll-like receptor signalling activation and monocyte recruitment.

Authors:  Shyam Sushama Jose; Marco De Zuani; Federico Tidu; Marcela Hortová Kohoutková; Lucia Pazzagli; Giancarlo Forte; Roberta Spaccapelo; Teresa Zelante; Jan Frič
Journal:  Clin Transl Immunology       Date:  2020-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.